Importantly, recent findings further support positive genetic association of circulating ACE2 with severe COVID‐19, CVD, asthma, diabetes, and hypertension, as well as causal effect of circulating ACE2 on COVID‐19 infection, hospitalization, and severity.14 The gene discussed is ACE2; the disease is asthma.